AI & Technical question
Abridge’s evals platform has to serve ambient notes, billing, and clinical decision support across 10+ pods. How would you design a shared evaluation framework, datasets, metric taxonomy, thresholds, and review workflows, that is consistent enough to be a trusted company standard, but still lets each pod define workflow-specific quality without fragmenting the platform?
- Abridge
- AI & Technical
- Hard
Practice this question out loud. An AI interviewer asks it, follows up like a real interviewer would, and scores your answer. Type or speak.
Start a mock interview on this question · Mock interview from a job description
What this question tests
Tests platform design skill: building a shared evaluation standard across many teams without either fragmenting it or forcing one size fits all quality bars.
How to approach it
- Define a shared metric taxonomy, accuracy, completeness, safety, latency, that every pod maps its workflow specific checks into.
- Centralize dataset infrastructure and tooling so pods do not each build their own eval pipeline from scratch.
- Let each pod set its own thresholds within the shared taxonomy, since a billing error and a clinical note error are not equally risky.
- Require a minimum bar, for example every pod must have an automated critical error check, as the non negotiable company standard.
- Run a cross pod council periodically to review new pod specific metrics before they are added, so the taxonomy does not sprawl.
What a strong answer includes
- Separates the shared taxonomy, structure, from workflow specific thresholds, content, so pods keep autonomy without fragmenting the platform.
- Centralizes tooling and datasets as shared infrastructure while decentralizing the actual quality bar decisions to domain experts in each pod.
- Uses a lightweight review council instead of a heavyweight approval process, so pods are not blocked from adding needed metrics.
Common mistakes
- Forcing one universal quality bar across ambient notes, billing, and decision support, which are not comparable risk profiles.
- Letting every pod build its own eval tooling, which fragments the platform and duplicates effort.
Likely follow-up questions
- How would you handle a pod that wants a metric outside the shared taxonomy?
- What would you standardize first if you had to launch this in one quarter?
More ai & technical questions
- Abridge has a post-training approach that uses clinician edits, final notes, and EHR context to improve note generation. How would you define the hypotheses, stage gates, and success metrics to take it from offline research to shadow mode to a limited production launch? What evidence would be required at each step to continue, pause, or kill the effort?Abridge · AI & Technical · Hard
- For a model that turns patient-clinician conversations into structured clinical notes, what evaluation suite would you use beyond aggregate quality scores? Specify the failure modes you would prioritize, how you would segment risk by workflow or note type, and the thresholds or escalation paths you would require before declaring the model safe enough to scale.Abridge · AI & Technical · Hard
- Abridge has access to de-identified conversations, clinician edits, final signed notes, EHR context, and downstream care actions, but each signal differs in coverage, cost, bias, and clinical relevance. How would you prioritize which signals to use first for post-training, and what framework would you use to decide whether a sparse, subjective, or expensive signal is still worth operationalizing?Abridge · AI & Technical · Hard
- A chart-aware CDS assistant must feel fast enough for live clinical use while staying reliable and evidence-grounded. How would you work with engineering and ML to define the system tradeoffs and product requirements around latency, retrieval quality, grounding, fallback behavior, and failure handling, and what technical or model-level changes would you prioritize first if response time improved only by reducing answer quality?Abridge · AI & Technical · Hard
- Abridge has a new AI-assisted clinician workflow whose model quality is improving but still imperfect. What launch criteria would you set before exposing it in live care, how would you combine offline evals, human review, and UX guardrails, and how would you phase the rollout to manage clinical and compliance risk?Abridge · AI & Technical · Hard
- Production monitoring shows a model improves average note quality but increases rare critical errors. How would you investigate whether this is a measurement artifact, a distribution shift, or a real safety regression, and how would you decide between shipping, pausing, rolling back, or narrowing scope?Abridge · AI & Technical · Hard
More questions from Abridge
Learn the skill behind it
Chapters of the AI PM course that teach what this question tests.
- Chapter 1: Foundations: the model and the decisions it forces on you
- Chapter 8: Evals: define good and make the number defensible
- Chapter 6: Agents and agentic architecture